Bought into this last Friday. RGS has got a great cash deal for one product in one market, and a JV partner who will assist in trials and licensing, regulatory etc.. On top of this there should be a good news flow over the next six months+ All up, what's not to like? Looks every bit as good, if not better than the CYP deal from what can be known about it.
Bought into this last Friday. RGS has got a great cash deal for...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
